MMA Reports: No tricks or treats—just facts
With the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), Congress required pharmaceutical companies to file certain patent settlement agreements with the FTC. Given the FTC’s unique role in reviewing these submissions, going back to 2004, staff of the Bureau of Competition publishes fiscal year MMA reports on the types of terms used in these settlements. These reports, and the data they contain about...